130 related articles for article (PubMed ID: 11201859)
1. Cost of Care.
Levy EG
Thyroid; 2000 Dec; 10(12):1119-21. PubMed ID: 11201859
[No Abstract] [Full Text] [Related]
2. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
Rudavsky AZ; Freeman LM
J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
[No Abstract] [Full Text] [Related]
3. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].
Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J
An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622
[No Abstract] [Full Text] [Related]
4. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R
Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
[TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
6. [Role of the nuclear medicine in the treatment of thyroid carcinoma].
Börner W; Reiners C
Med Klin; 1980 Jan; 75(2):80-7. PubMed ID: 7374606
[No Abstract] [Full Text] [Related]
7. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
[TBL] [Abstract][Full Text] [Related]
8. Incidental detection of a falx meningioma on post-therapy radioiodide whole-body imaging.
Sinha P; Conrad GR; Holzhauer M
Clin Nucl Med; 2002 Dec; 27(12):916-7. PubMed ID: 12607886
[No Abstract] [Full Text] [Related]
9. Management of thyroid cancer.
Blahd WH
Compr Ther; 1993; 19(5):197-202. PubMed ID: 8275665
[No Abstract] [Full Text] [Related]
10. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma.
Harder W; Lind P; Molnar M; Mikosch P; Gomez I; Gallowitsch HJ; Kresnik E; Unterweger O; Dinges HP
J Nucl Med; 1998 Feb; 39(2):236-8. PubMed ID: 9476925
[TBL] [Abstract][Full Text] [Related]
11. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
[TBL] [Abstract][Full Text] [Related]
12. Cystic ovarian metastasis from papillary thyroid carcinoma: a case report.
Logani S; Baloch ZW; Snyder PJ; Weinstein R; LiVolsi VA
Thyroid; 2001 Nov; 11(11):1073-5. PubMed ID: 11762718
[TBL] [Abstract][Full Text] [Related]
13. Thyroglobulin and 131I uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy.
Moser E; Fritsch S; Braun S
Nucl Med Commun; 1988 Apr; 9(4):262-6. PubMed ID: 3399222
[TBL] [Abstract][Full Text] [Related]
14. Papillary thyroid cancer: a pediatric perspective.
Flannery TK; Kirkland JL; Copeland KC; Bertuch AA; Karaviti LP; Brandt ML
Pediatrics; 1996 Sep; 98(3 Pt 1):464-6. PubMed ID: 8784379
[No Abstract] [Full Text] [Related]
15. [Serum thyroglobulin in the diagnosis of metastases of differentiated thyroid cancer. Effect of suppressive thyroid hormone substitution on the diagnostic accuracy of thyroglobulin values].
Müller-Gärtner HW; Schneider C; Tempel MT
Nuklearmedizin; 1986 Oct; 25(5):194-200. PubMed ID: 3797259
[TBL] [Abstract][Full Text] [Related]
16. The advantages of subtotal thyroidectomy and suppression of TSH in the primary treatment of papillary carcinoma of the thyroid.
Crile G; Antunez AR; Esselstyn CB; Hawk WA; Skillern PG
Cancer; 1985 Jun; 55(11):2691-7. PubMed ID: 3922611
[TBL] [Abstract][Full Text] [Related]
17. Management of papillary thyroid cancer patients in absence of postoperative radioiodine remnant ablation: tailoring follow-up by neck sonography.
Durante C; Filetti S
J Clin Endocrinol Metab; 2011 Oct; 96(10):3059-61. PubMed ID: 21795452
[No Abstract] [Full Text] [Related]
18. Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice.
Schlumberger M; Pacini F; Wiersinga WM; Toft A; Smit JW; Sanchez Franco F; Lind P; Limbert E; Jarzab B; Jamar F; Duntas L; Cohen O; Berg G
Eur J Endocrinol; 2004 Nov; 151(5):539-48. PubMed ID: 15538930
[TBL] [Abstract][Full Text] [Related]
19. [Clinical value of serum thyroglobulin and 131I-whole body retention measurements in the diagnosis of metastases from differentiated thyroid carcinoma (author's transl)].
Weissel M; Bergmann H; Höfer R
Acta Med Austriaca; 1980; 7(4-5):114-9. PubMed ID: 7246011
[No Abstract] [Full Text] [Related]
20. Classification of papillary thyroid microcarcinoma according to size and fine-needle aspiration cytology: Behavior and therapeutic implications.
Friguglietti CU; Dutenhefner SE; Brandão LG; Kulcsar MA
Head Neck; 2011 May; 33(5):696-701. PubMed ID: 20737499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
